ARK Investment Management disclosed on Monday that its exchange-traded funds purchased 169,357 shares of Intellia Therapeutics on Aug. 24, a $2.17 million commitment spread across the ARKK and ARKG funds. The purchase follows an earlier $1.52 million buy of 115,499 shares on Aug. 21, signaling a stepped-up allocation to the biotechnology firm.
The ARKK fund also reduced its position in Roblox by 26,199 shares on Aug. 24, a $1.01 million divestment that continues a pattern of trimming the gaming and entertainment company’s weighting. ARKK sold 26,616 shares on Aug. 21 and 163,494 shares the prior Thursday, totaling $1.25 million in reductions over three sessions.
ARKG added 12,938 shares of Perceptive Capital Solutions for $178,673 on Aug. 24, extending a series of smaller purchases recorded earlier in the week. Conversely, a trio of ARK funds—ARKK, ARKW and ARKF—collectively disposed of 10,661 shares of Brera Holdings PLC for $45,629, part of a broader reduction in the company’s weighting.
The trades reflect ARK’s strategy of rotating capital into biotechnology while paring back exposure to gaming and other sectors. Intellia’s shares have gained ground this year amid progress in gene-editing therapies, while Roblox has faced volatility tied to shifting user engagement trends. The latest disclosures cover the Aug. 24 trading session and were published by ARK on Monday.
